Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda (1993)
Chapter: B9. Antiprogestins and the Treatment of Breast Cancer
Unfortunately, this book can't be printed from the OpenBook.
If you need to print pages from this book, we recommend
downloading it as a PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter:
B8. Use of Antiprogestins in the Management of Endometriosis and Leiomyoma
Next Chapter: B10. Uses of RU 486 as an Antiglucocoticoid
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Suggested Citation:
"B9. Antiprogestins and the Treatment of Breast Cancer." Institute of Medicine. 1993. Clinical Applications of Mifepristone (RU486) and Other Antiprogestins: Assessing the Science and Recommending a Research Agenda. Washington, DC: The National Academies Press.
doi: 10.17226/2203.
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.